HIV/AIDS: Research and Palliative Care (Mar 2021)

Effect of the Test and Treat Strategy on Mortality Among HIV-Positive Adult Clients on Antiretroviral Treatment in Public Hospitals of Addis Ababa, Ethiopia

  • Tesfaye B,
  • Ermias D,
  • Moges S,
  • Astatkie A

Journal volume & issue
Vol. Volume 13
pp. 349 – 360

Abstract

Read online

Bereket Tesfaye,1 Dejene Ermias,2 Sisay Moges,3 Ayalew Astatkie4 1USAID Family-Focused HIV Prevention Care and Support Program Integrated Services for Health and Development Organization, Addis Ababa, Ethiopia; 2Public Health Department, College of Medicine & Health Sciences, Wachemo University, Hosanna, Ethiopia; 3Department of Health Informatics, Hosanna College of Health Sciences, Hosanna, Ethiopia; 4School of Public Health, College of Medicine and Health Sciences, Hawassa University, Hawassa, EthiopiaCorrespondence: Dejene Ermias Email [email protected]: The primary goal of antiretroviral therapy is to prevent human immune deficiency virus (HIV)-related morbidity and mortality. Deferring antiretroviral therapy (ART) until CD4 counts decline puts individuals with HIV at risk of HIV-related morbidity and mortality.Objective: This study aims to assess the effect of the test and treat strategy on mortality among HIV-positive clients on ART in public hospitals in Addis Ababa.Methods: A retrospective cohort study was conducted at five selected public hospitals in Addis Ababa. A cohort of 216 ART clients taken as an exposed group (test and treat” strategy) from 2017 to 2019 and 216 ART clients as an unexposed group taken from 2014 to 2017; totally, 432 clients were included in the study. Multivariate Cox regression was used to estimate the effect of the test and treat strategy on the survival of ART clients adjusting for other covariates.Results: The 432 clients contributed to a total of 1025.17 person-years follow-up. Ninety-one (21.06%) of them died, 14.3% were unexposed and 6.7% were exposed (test and treat). The incidence of death was 92.4 and 81.8/1000 person-years in the unexposed group and exposed group, respectively, with an overall mortality rate of 88.8/1000 person-years. Besides, test and treat strategy (AHR: 0.31; 95% CI: 0.19, 0.52), baseline CD4 counts > 350 cells/mm3 (AHR 0.40; 95%: CI: 0.20, 0.80), bedridden functional status (AHR 2.46; 95% CI: 1.41, 4.27), poor adherence (AHR 3.25; 95% CI: 1.410– 7.51), moderate malnutrition on last visit (AHR 2.56; 95% CI: 1.30– 5.04) and staying on original regimen (AHR 4.68; 95% CI 2.72, 8.07) were independent predictors of mortality.Conclusion: Mortality among HIV patients on treatment decreased significantly since the start of the test and treat strategy. Therefore, test and treat strategy should be strengthened in all public and private facilities throughout the country.Keywords: test and treat, mortality, HIV/AIDS, Addis Ababa, Ethiopia

Keywords